Activities of Nicola CAPUTO related to 2017/2030(INI)
Plenary speeches (1)
Implementation of the 7th Environment Action Programme (debate) IT
Amendments (9)
Amendment 59 #
Motion for a resolution
Paragraph 5
Paragraph 5
5. Is concerned that specialised knowledge is not always fully used in policy-making or transferred to the parties responsible for implementation; highlights the examples of bioenergy, endocrine disrupters, palm oil and food production in general as areas where evidence of risks to human health and the environment has been sidelined;
Amendment 63 #
Motion for a resolution
Paragraph 5 b (new)
Paragraph 5 b (new)
5b. Deplores that the Commission failed to meet the deadline for drafting harmonised hazard-based criteria for the identification of endocrine disruptors set out by law;
Amendment 65 #
Motion for a resolution
Paragraph 5 c (new)
Paragraph 5 c (new)
5c. Deplores that there has not been satisfactory development on setting out a comprehensive approach to minimising exposure to hazardous substances, including chemicals in products;
Amendment 66 #
Motion for a resolution
Paragraph 5 d (new)
Paragraph 5 d (new)
5d. Regrets that the Union so far failed to make progress in developing a Union strategy for a non-toxic environment that is conducive to innovation and the development of sustainable substitutes including non- chemical solutions, building on horizontal measures to be undertaken by 2015 to ensure: the safety of manufactured nanomaterials and materials with similar properties; the minimisation of exposure to endocrine disruptors; appropriate regulatory approaches to address combination effects of chemicals and the minimisation of exposure to chemicals in products, including, inter alia, imported products, with a view to promoting non- toxic material cycles and reducing indoor exposure to harmful substances;
Amendment 67 #
Motion for a resolution
Paragraph 5 e (new)
Paragraph 5 e (new)
5e. Regrets that the Commission’s obligation to review the Cosmetics Regulation with regard to endocrine disruptors no later than January 2015 has not been fulfilled despite several reminders from consumers’ and health organisations, the Parliament and scientific community and despite the Commission’s commitment that they would finalise the review by the end of 2016; calls on the Commission to immediately review the Cosmetics Regulation with regard to endocrine disruptors without any further delays;
Amendment 68 #
Motion for a resolution
Paragraph 5 f (new)
Paragraph 5 f (new)
5f. Highlights that efforts need to be stepped up to ensure that, by 2020, all relevant substances of very high concern, including substances with endocrine- disrupting properties, are placed on the REACH candidate list;
Amendment 158 #
Motion for a resolution
Paragraph 16 a (new)
Paragraph 16 a (new)
16a. In order to safeguard the Union’s citizens from environment-related pressures and risks to health and well- being, calls on the Commission and the Member States to ensure that the combination effects of chemicals and safety concerns related to endocrine disruptors are effectively addressed in all relevant Union legislation, and risks for the environment and health, in particular in relation to children, associated with the use of hazardous substances, including chemicals in products, are assessed and minimised by 2020;
Amendment 161 #
Motion for a resolution
Paragraph 16 b (new)
Paragraph 16 b (new)
16b. Calls on the Commission to ensure that long-term actions with a view to reaching the objective of a non-toxic environment will be identified by 2020;
Amendment 196 #
Motion for a resolution
Paragraph 20 a (new)
Paragraph 20 a (new)
20a. Calls on the Commission to elaborate a wide strategy for EU areas under high environmental pressure in order to promote exchange of best practices regarding remediation operations and risk prevention for human health;